Details
Nothing to say, yet
Details
Nothing to say, yet
Comment
Nothing to say, yet
NeuroCare, led by Zoe Bloss, is in a difficult situation. The CEO wants to fake results to get more funding, but this goes against the company's ethics and could harm its reputation. As a product manager, it's important to think about the ethical implications and the company's mission to save lives. My chosen dilemma is case two. NeuroCare, under the leadership of Zoe Bloss, faces a critical juncture where the ethical integrity of its business practices are being tested. The CEO's directive to falsely demonstrate results in order to secure additional funding poses significant ethical and professional challenges, risking the company's reputation and long-term success for a potential short-term benefit. As a product manager, navigating the situation requires careful consideration of the ethical implications, potential risks, and the company's overachieving mission to innovate and save lives.